[德国风湿病学会关于包括贝赫切特病和早期形式的轴性脊柱关节炎的S3指南：8.4药物治疗，8.5药物治疗措施的疗效评估] - Suppr

Suppr

超能文献

[German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 8.4 Pharmaceutical therapy, 8.5 Evaluation of therapy success of pharmaceutical measures].

作者信息

Kiltz U, Sieper J, Kellner H, Krause D, Rudwaleit M, Chenot J-F, Stallmach A, Jaresch S, Braun J

机构信息

Deutsche Gesellschaft für Rheumatologie (DGRh), Berlin, Deutschland,

出版信息

Z Rheumatol. 2014 Sep;73 Suppl 2:78-96. doi: 10.1007/s00393-014-1443-7.

DOI:10.1007/s00393-014-1443-7

PMID:25181978

Abstract

摘要

相似文献

[German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 8.4 Pharmaceutical therapy, 8.5 Evaluation of therapy success of pharmaceutical measures].[德国风湿病学会关于包括贝赫切特病和早期形式的轴性脊柱关节炎的S3指南：8.4药物治疗，8.5药物治疗措施的疗效评估]

Z Rheumatol. 2014 Sep;73 Suppl 2:78-96. doi: 10.1007/s00393-014-1443-7.

[German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 8 Therapy, 8.1 Treatment concept, 8.2 Therapy targets and strategy].[德国风湿病学会关于包括贝赫切特病和早期形式在内的轴性脊柱关节炎的S3指南：8治疗，8.1治疗理念，8.2治疗目标和策略]

Z Rheumatol. 2014 Sep;73 Suppl 2:69-70. doi: 10.1007/s00393-014-1433-9.

[German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 8.3 Nonpharmaceutical therapeutic measures].[德国风湿病学会关于包括贝赫切特病和早期形式在内的轴向型脊柱关节炎的S3指南：8.3非药物治疗措施]

Z Rheumatol. 2014 Sep;73 Suppl 2:71-7. doi: 10.1007/s00393-014-1442-8.

[German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: Editorial].[德国风湿病学会关于包括贝赫切特病和早期形式的轴性脊柱关节炎的S3指南：编者按]

Z Rheumatol. 2014 Sep;73 Suppl 2:20-2. doi: 10.1007/s00393-014-1425-9.

[German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 2 Preamble].[德国风湿病学会关于包括贝赫切特病和早期形式的轴性脊柱关节炎的S3指南：2引言]

Z Rheumatol. 2014 Sep;73 Suppl 2:26-7. doi: 10.1007/s00393-014-1427-7.

[German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 8.7 Rehabilitation].[德国风湿病学会关于包括贝赫切特病和早期形式的轴向型脊柱关节炎的S3指南：8.7康复]

Z Rheumatol. 2014 Sep;73 Suppl 2:101-3. doi: 10.1007/s00393-014-1445-5.

[German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 7 Disease activity and prognosis of spondyloarthritis].[德国风湿病学会关于包括贝赫切特病和早期形式在内的轴向型脊柱关节炎的S3指南：7. 脊柱关节炎的疾病活动度和预后]

Z Rheumatol. 2014 Sep;73 Suppl 2:66-8. doi: 10.1007/s00393-014-1432-x.

[German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 6 Diagnostics].[德国风湿病学会关于包括贝赫切特病和早期形式在内的轴性脊柱关节炎的S3指南：6. 诊断]

Z Rheumatol. 2014 Sep;73 Suppl 2:49-65. doi: 10.1007/s00393-014-1431-y.

[German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 1 Introduction/preliminary comments].[德国风湿病学会关于包括贝赫切特病和早期形式的轴向型脊柱关节炎的S3指南：1引言/初步评论]

Z Rheumatol. 2014 Sep;73 Suppl 2:23-5. doi: 10.1007/s00393-014-1426-8.

[German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 4 Classification and diagnostic criteria].[德国风湿病学会关于包括贝赫切雷夫病和早期形式在内的轴性脊柱关节炎的S3指南：4分类和诊断标准]

Z Rheumatol. 2014 Sep;73 Suppl 2:40-3. doi: 10.1007/s00393-014-1429-5.

引用本文的文献

Etanercept in Axial Spondyloarthritis, Psoriatic Arthritis, and Plaque Psoriasis: Real-World Outcome Data from German Non-interventional Study ADEQUATE.依那西普治疗强直性脊柱炎、银屑病关节炎和斑块状银屑病：来自德国非干预性研究ADEQUATE的真实世界结局数据。

Rheumatol Ther. 2024 Apr;11(2):331-348. doi: 10.1007/s40744-023-00633-2. Epub 2024 Feb 3.

[Biologics and further new drugs for rheumatic diseases since 2000].[2000年以来用于风湿性疾病的生物制剂及其他新药]

Orthopade. 2018 Nov;47(11):906-911. doi: 10.1007/s00132-018-3650-4.

Spine Fractures in Ankylosing Diseases: Recommendations of the Spine Section of the German Society for Orthopaedics and Trauma (DGOU).强直性疾病中的脊柱骨折：德国矫形外科学与创伤学会（DGOU）脊柱分会的建议

Global Spine J. 2018 Sep;8(2 Suppl):56S-68S. doi: 10.1177/2192568217736268. Epub 2018 Sep 7.

Access criteria for anti-TNF agents in spondyloarthritis: influence on comparative 1-year cost-effectiveness estimates.脊柱关节炎中抗TNF药物的准入标准：对1年比较性成本效益估计的影响

Cost Eff Resour Alloc. 2017 Sep 7;15:20. doi: 10.1186/s12962-017-0081-8. eCollection 2017.

[Evidence-based recommendations on diagnostics and therapy of axial spondyloarthritis : S3 guidelines of the German Society of Rheumatology (DGRh) in cooperation with the Association of the Scientific Medical Societies in Germany (AWMF)].[轴性脊柱关节炎诊断与治疗的循证推荐：德国风湿病学会（DGRh）与德国科学医学协会联盟（AWMF）合作制定的S3指南]

Z Rheumatol. 2017 Mar;76(2):111-117. doi: 10.1007/s00393-016-0232-x.

[Management of axial spondyloarthritis].[中轴型脊柱关节炎的管理]

Internist (Berl). 2016 Nov;57(11):1060-1068. doi: 10.1007/s00108-016-0140-9.

本文引用的文献

[ASAS recommendations on the use of TNF inhibitors for patients with axial spondyloarthritis : evaluation of the 2010 update in the German-speaking area].

Z Rheumatol. 2013 Feb;72(1):81-8. doi: 10.1007/s00393-012-1089-2.

Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1).阿达木单抗治疗非放射性轴性脊柱关节炎患者的疗效和安全性：一项随机安慰剂对照试验（ABILITY-1）的结果。

Ann Rheum Dis. 2013 Jun;72(6):815-22. doi: 10.1136/annrheumdis-2012-201766. Epub 2012 Jul 7.

Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis.连续使用非甾体抗炎药可逆转强直性脊柱炎患者炎症对放射学进展的影响。

Ann Rheum Dis. 2012 Oct;71(10):1623-9. doi: 10.1136/annrheumdis-2012-201370. Epub 2012 Apr 24.

Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort.非甾体抗炎药对轴性脊柱关节炎患者放射学脊柱进展的影响：来自德国脊柱关节炎起始队列的结果。

Ann Rheum Dis. 2012 Oct;71(10):1616-22. doi: 10.1136/annrheumdis-2011-201252. Epub 2012 Mar 29.

Early response to adalimumab predicts long-term remission through 5 years of treatment in patients with ankylosing spondylitis.在强直性脊柱炎患者中，阿达木单抗的早期应答可预测治疗 5 年内的长期缓解。

Ann Rheum Dis. 2012 May;71(5):700-6. doi: 10.1136/annrheumdis-2011-200358. Epub 2011 Nov 29.

Golimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo- controlled GO-RAISE study.戈利木单抗可减轻强直性脊柱炎的脊柱炎症：随机、安慰剂对照 GO-RAISE 研究的 MRI 结果。

Ann Rheum Dis. 2012 Jun;71(6):878-84. doi: 10.1136/annrheumdis-2011-200308. Epub 2011 Nov 29.

Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 104-week results of the GO-RAISE study.戈利木单抗每 4 周皮下注射治疗强直性脊柱炎：GO-RAISE 研究的 104 周结果。

Ann Rheum Dis. 2012 May;71(5):661-7. doi: 10.1136/ard.2011.154799. Epub 2011 Oct 19.

The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximab.欧洲强直性脊柱炎英夫利昔单抗队列研究（EASIC）：一项关于使用英夫利昔单抗治疗强直性脊柱炎患者的长期结局的欧洲多中心研究。

Clin Exp Rheumatol. 2011 Jul-Aug;29(4):672-80. Epub 2011 Aug 31.

Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis.登记处和前瞻性观察研究中与肿瘤坏死因子抑制剂相关的恶性肿瘤：系统评价和荟萃分析。

Ann Rheum Dis. 2011 Nov;70(11):1895-904. doi: 10.1136/ard.2010.149419. Epub 2011 Sep 1.

Norms-based assessment of patient-reported outcomes associated with adalimumab monotherapy in patients with ankylosing spondylitis.基于规范的评估：阿达木单抗单药治疗强直性脊柱炎患者相关的患者报告结局。

Clin Exp Rheumatol. 2011 Jul-Aug;29(4):624-32. Epub 2011 Aug 31.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验